1. Home
  2. IMCC vs MYNZ Comparison

IMCC vs MYNZ Comparison

Compare IMCC & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • MYNZ
  • Stock Information
  • Founded
  • IMCC 1980
  • MYNZ 2021
  • Country
  • IMCC Israel
  • MYNZ Germany
  • Employees
  • IMCC N/A
  • MYNZ N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMCC Health Care
  • MYNZ Health Care
  • Exchange
  • IMCC Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • IMCC 5.0M
  • MYNZ N/A
  • IPO Year
  • IMCC N/A
  • MYNZ 2021
  • Fundamental
  • Price
  • IMCC $2.23
  • MYNZ $0.31
  • Analyst Decision
  • IMCC
  • MYNZ Buy
  • Analyst Count
  • IMCC 0
  • MYNZ 2
  • Target Price
  • IMCC N/A
  • MYNZ $3.00
  • AVG Volume (30 Days)
  • IMCC 11.8K
  • MYNZ 2.3M
  • Earning Date
  • IMCC 11-11-2024
  • MYNZ 11-14-2024
  • Dividend Yield
  • IMCC N/A
  • MYNZ N/A
  • EPS Growth
  • IMCC N/A
  • MYNZ N/A
  • EPS
  • IMCC N/A
  • MYNZ N/A
  • Revenue
  • IMCC $36,445,402.00
  • MYNZ $917,203.00
  • Revenue This Year
  • IMCC $22.59
  • MYNZ $36.69
  • Revenue Next Year
  • IMCC $20.53
  • MYNZ $91.67
  • P/E Ratio
  • IMCC N/A
  • MYNZ N/A
  • Revenue Growth
  • IMCC N/A
  • MYNZ 16.23
  • 52 Week Low
  • IMCC $1.13
  • MYNZ $0.19
  • 52 Week High
  • IMCC $8.10
  • MYNZ $3.39
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 41.06
  • MYNZ 51.63
  • Support Level
  • IMCC $2.02
  • MYNZ $0.28
  • Resistance Level
  • IMCC $2.15
  • MYNZ $0.33
  • Average True Range (ATR)
  • IMCC 0.14
  • MYNZ 0.05
  • MACD
  • IMCC -0.01
  • MYNZ 0.00
  • Stochastic Oscillator
  • IMCC 19.15
  • MYNZ 42.69

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: